BRIDGEWAY CAPITAL MANAGEMENT, LLC - CHINA PHARMA HLDGS INC ownership

CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 7 filers reported holding CHINA PHARMA HLDGS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of CHINA PHARMA HLDGS INC
ValueSharesWeighting
Q4 2022$13,906
-26.8%
145,0000.0%0.00%
-100.0%
Q3 2022$19,000
-54.8%
145,000
-25.6%
0.00%0.0%
Q2 2022$42,000
-44.7%
195,0000.0%0.00%0.0%
Q1 2022$76,000
-19.1%
195,0000.0%0.00%
-50.0%
Q4 2021$94,000
-13.8%
195,0000.0%0.00%0.0%
Q3 2021$109,000
-22.7%
195,0000.0%0.00%
-33.3%
Q2 2021$141,000
-28.4%
195,000
-17.0%
0.00%
-25.0%
Q1 2021$197,000
+87.6%
235,0000.0%0.00%
+100.0%
Q4 2020$105,000
+22.1%
235,0000.0%0.00%0.0%
Q3 2020$86,000
-45.2%
235,0000.0%0.00%
-33.3%
Q2 2020$157,000235,0000.00%
Other shareholders
CHINA PHARMA HLDGS INC shareholders Q1 2021
NameSharesValueWeighting ↓
POPE ASSET MANAGEMENT, LLC 2,104,826$632,0000.51%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 1,290,463$387,0000.07%
GLENHILL ADVISORS LLC 200,000$60,0000.01%
Renaissance Technologies 136,300$41,0000.00%
Virtu KCG Holdings LLC 19,910$6,0000.00%
UBS Group AG 5,618$2,0000.00%
View complete list of CHINA PHARMA HLDGS INC shareholders